4Filed Aug 23, 8:00 PM ET

OptimizeRx (OPRX) CBO Andrew D'Silva Sells 1,243 Shares

$OPRX · OptimizeRx Corp

Research Summary

AI-generated summary of this SEC filing

Updated

OptimizeRx (OPRX) CBO Andrew D'Silva Sells 1,243 Shares

What Happened Andrew D'Silva, Chief Business Officer of OptimizeRx Corp (OPRX), had 1,243 shares withheld by the company on August 21, 2026 to satisfy tax withholding obligations related to vesting restricted stock units. The shares were valued at $7.71 each, totaling $9,584. This withholding is recorded as a disposition (sale) under Section 16 rules but reflects tax withholding on an award rather than an open‑market sale.

Key Details

  • Transaction date: 2026-08-21
  • Action/type: Tax withholding upon RSU vesting (transaction code F) — treated as a disposition
  • Shares withheld/disposed: 1,243 shares at $7.71 per share; total ~$9,584
  • Shares owned after transaction: Not specified in the provided filing
  • Footnote: The issuer withheld shares to satisfy the reporting person’s tax withholding obligations (Footnote F1).
  • Filing: Form 4 filed 2026-08-24; filing appears timely relative to the reported transaction date.

Context This was a tax-withholding disposition tied to RSU vesting (a routine administrative action), not a voluntary open-market sale. Such withholdings are commonly recorded as dispositions under SEC rules but do not necessarily indicate insider sentiment about the company’s stock.